Plasma exchange in the treatment of thyroid storm secondary to type II amiodarone-induced thyrotoxicosis

Por Zhu, Ling, Zainudin, Sueziani Binte, Kaushik, Manish, Khor, Li Yan, Chng, Chiaw Ling
Publicado no Endocrinol Diabetes Metab Case Rep (2016)

Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer

Por Pollack, Alan, Kwon, Deukwoo, Walker, Gail, Khor, Li Yan, Horwitz, Eric M., Buyyounouski, Mark K., Stoyanova, Radka
Publicado no J Natl Cancer Inst (2017)

Adenoviral-E2F-1 Radiosensitizes p53(wild-type) and p53(null) Human Prostate Cancer Cells

Por Nguyen, Khanh H., Hachem, Paul, Khor, Li-Yan, Salem, Naji, Hunt, Kelly K., Calkins, Peter R., Pollack, Alan
Publicado no Int J Radiat Oncol Biol Phys (2005)

ANTISENSE-MDM2 SENSITIZES LNCaP PROSTATE CANCER CELLS TO ANDROGEN DEPRIVATION, RADIATION, AND THE COMBINATION IN VIVO

Por Stoyanova, Radka, Hachem, Paul, Hensley, Harvey, Khor, Li-Yan, Mu, Zhaomei, Hammond, M. Elizabeth H., Agrawal, Sudhir, Pollack, Alan
Publicado em 2007

PKA Knockdown Enhances Cell Killing In Response To Radiation And Androgen Deprivation

Por Hensley, Harvey H., Hannoun-Levi, Jean-Michel, Hachem, Paul, Mu, Zhaomei, Stoyanova, Radka, Khor, Li-Yan, Agrawal, Sudhir, Pollack, Alan
Publicado em 2010

Ki-67 is an Independent Predictor of Metastasis and Cause-Specific Mortality for Prostate Cancer Patients Treated on Radiation Therapy Oncology Group (RTOG) 94-08

Por Verhoven, Bret, Yan, Yan, Ritter, Mark, Khor, Li-Yan, Hammond, Elizabeth, Jones, Christopher, Amin, Mahul, Bahary, Jean-Paul, Zeitzer, Kenneth, Pollack, Alan
Publicado em 2013

Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression

Por Xu, Xu-Zhi, Garcia, Marileila Varella, Li, Tian-yu, Khor, Li-Yan, Gajapathy, R Sujatha, Spittle, Cindy, Weed, Scott, Lessin, Stuart R, Wu, Hong
Publicado em 2009

Prognostic Value of p16 in Locally Advanced Prostate Cancer: A Study Based on Radiation Therapy Oncology Group Protocol 9202

Por Chakravarti, Arnab, DeSilvio, Michelle, Zhang, Min, Grignon, David, Rosenthal, Seth, Asbell, Sucha O., Hanks, Gerald, Sandler, Howard M., Khor, Li-Yan, Pollack, Alan, Shipley, William
Publicado em 2007

BCL-2 AND BAX EXPRESSION AND PROSTATE CANCER OUTCOME IN MEN TREATED WITH RADIOTHERAPY IN RADIATION THERAPY ONCOLOGY GROUP PROTOCOL 86–10

Por khor, Li-Yan, Desilvio, Michelle, Li, Rile, McDonnell, Timothy J., Hammond, M. Elizabeth H., Sause, William T., Pilepich, Miljenko V., Okunieff, Paul, Sandler, Howard M., Pollack, Alan
Publicado em 2006

Protein Kinase A RI-alpha (PKA) Predicts Prostate Cancer Outcome: An Analysis of Radiation Therapy Oncology Group Trial 86-10

Por Khor, Li-Yan, Bae, Kyounghwa, Al-Saleem, Tahseen, Hammond, Elizabeth H., Grignon, David J., Sause, William T., Pilepich, Miljenko V., Okunieff P, Paul, Sandler, Howard M., Pollack, Alan
Publicado em 2008

The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02

Por Pollack, Alan, Bae, Kyounghwa, Khor, Li-Yan, Al-Saleem, Tahseen, Hammond, M. Elizabeth, Venkatesan, Varagur, Byhardt, Roger W., Asbell, Sucha O., Shipley, William U., Sandler, Howard M.
Publicado em 2009

SURVIVIN IS A POTENTIAL MEDIATOR OF PROSTATE CANCER METASTASIS

Por Zhang, Min, Coen, John J., Suzuki, Yoshiyuki, Siedow, Michael R., Niemierko, Andrzej, Khor, Li-Yan, Pollack, Alan, Zhang, Yifen, Zietman, Anthony L., Shipley, William U., Chakravarti, Arnab
Publicado no Int J Radiat Oncol Biol Phys (2010)

THE PROGNOSTIC VALUE OF SURVIVIN IN LOCALLY ADVANCED PROSTATE CANCER: A STUDY BASED ON RTOG 8610

Por Zhang, Min, Ho, Alex, Hammond, Elizabeth H., Suzuki, Yoshiyuki, Bermudez, R. Scott, Lee, R. Jeffrey, Pilepich, Michael, Shipley, William U., Sandler, Howard, Khor, Li-Yan, Pollack, Alan, Chakravarti, Arnab
Publicado em 2008

Bcl-2 and Bax Expression Predict Prostate Cancer Outcome in Men Treated with Androgen Deprivation and Radiotherapy on Radiation Therapy Oncology Group Protocol 92-02

Por Khor, Li Yan, Moughan, Jennifer, Al-Saleem, Tahseen, Hammond, Elizabeth H., Venkatesan, Varagur, Rosenthal, Seth A., Ritter, Mark A., Sandler, Howard M., Hanks, Gerald E., Shipley, William U., Pollack, Alan
Publicado em 2007

MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02

Por Khor, Li-Yan, Bae, Kyounghwa, Paulus, Rebecca, Al-Saleem, Tahseen, Hammond, M. Elizabeth, Grignon, David J., Che, Mingxin, Venkatesan, Varagur, Byhardt, Roger W., Rotman, Marvin, Hanks, Gerald E., Sandler, Howard M., Pollack, Alan
Publicado em 2009

COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial

Por Khor, Li-Yan, Bae, Kyounghwa, Pollack, Alan, Hammond, M Elizabeth, Grignon, David J, Venkatesan, Varagur M, Rosenthal, Seth A, Ritter, Mark A, Sandler, Howard M, Hanks, Gerald E, Shipley, William U, Dicker, Adam P
Publicado em 2007

Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate Cancer

Por Heckman, Michael G., Tzou, Katherine S., Parker, Alexander S., Pisansky, Thomas M., Schild, Steven E., Hilton, Tracy W., Patel, Vivek N., Pelaez, Liset, Khor, Li Yan, Peterson, Jennifer L., Daugherty, Larry C., Vallow, Laura A., Pollack, Alan, Buskirk, Steven J.
Publicado em 2013